Singapore markets close in 1 hour 30 minutes

Nemaura Medical Inc. (NMRD)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0567-0.0083 (-12.78%)
At close: 01:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.64M
Enterprise value 21.14M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)712.42
Price/book (mrq)N/A
Enterprise value/revenue 7.18k
Enterprise value/EBITDA -4.70

Trading information

Stock price history

Beta (5Y monthly) -0.06
52-week change 3-92.30%
S&P500 52-week change 321.08%
52-week high 31.2500
52-week low 30.0530
50-day moving average 30.0805
200-day moving average 30.2958

Share statistics

Avg vol (3-month) 338.59k
Avg vol (10-day) 340.31k
Shares outstanding 528.9M
Implied shares outstanding 628.9M
Float 818.83M
% held by insiders 148.62%
% held by institutions 14.41%
Shares short (15 Dec 2023) 452.57k
Short ratio (15 Dec 2023) 40.3
Short % of float (15 Dec 2023) 40.31%
Short % of shares outstanding (15 Dec 2023) 40.18%
Shares short (prior month 15 Nov 2023) 4192.2k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 305 Dec 2019
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 305 Dec 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-81.19%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -11.29M
Net income avi to common (ttm)-10.65M
Diluted EPS (ttm)-0.3900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)137.42k
Total cash per share (mrq)0
Total debt (mrq)19.64M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.19
Book value per share (mrq)-0.62

Cash flow statement

Operating cash flow (ttm)-9.57M
Levered free cash flow (ttm)-10.07M